IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MPLT

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Cash & Equivalents71.6355.7146.7364.15
Short-term Investments233.09254.41258.37163.02
Total Current Assets318.79327.23324.67245.31
Property, Plant & Equipment0.830.971.100.86
Total Non-current Assets*49.5691.56154.8411.92
Total Assets368.35418.79479.51257.22
Accounts Payable2.053.193.292.45
Total Current Liabilities19.2914.2816.2318.56
Total Non-current Liabilities*0.764.674.915.14
Total Liabilities20.0518.9521.1423.71
Retained Earnings(481.38)(421.19)(360.52)(280.97)
Total Stockholder Equity348.30399.83458.37(274.18)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Research & Development53.4453.6864.6227.09
Selling, General & Admin10.1110.8218.754.40
Total Operating Expenses63.5564.5083.3831.50
Operating Income(63.55)(64.50)(83.38)(31.50)
Net Income(60.19)(60.67)(79.55)(29.42)
Basic EPS(1.32)(1.34)87.14(37.18)
Diluted EPS(1.32)(1.34)87.14(37.18)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Operating Cash Flow(44.87)(51.18)(46.83)(91.31)
Capital Expenditures0.020.020.380.10
Free Cash Flow*(44.89)(51.20)(47.20)(91.40)
Investing Cash Flow60.7067.01(242.55)(80.65)
Financing Cash Flow0.09(6.85)271.96197.86
← Scroll for more columns →

* Derived from reported values